Cryosurgery for kidney cancer
was first introduced in 1999. It involves freezing tissue to extremely cool temperatures (-190 Celsius) in order to kill the cells. The mechanism of this includes
destruction of the cell wall, orgenelles within the cell and prohibiting blood
from circulating. With the advent of newer delivery systems and ultrasound
guidance one can destroy a focal area of tissue/cancer with accuracy up to
2.5mm.
Dermatologists have the most
experience with cryosurgery for treating cancers of the skin. Within the last
decade urologists have chosen to use this technology for the treatment of
prostate cancer. Most recently other applications have been explored including
the use of treating liver cancer, bone and kidney cancer.
At New York Presbyterian
Hospital they are most interested in utilizing cryosurgery for the treatment
and cure of small kidney cancers. About half of all patients with kidney cancer
are diagnosed "incidentally". That is a test such as an ultrasound
or CT scan was ordered for another issue and "incidentally" a kidney
tumour was discovered.
Small isolated
tumours treatments options consist of removing part if not all the kidney.
Another treatment option being investigated is cryosurgery of the kidney tumour.
For patients with only one kidney or decreased renal function, where removal
of a portion of the entire kidney would mean dialysis for life, cryosurgery
holds great promise.
Cryosurgery
of the kidney is performed laparoscopically. Three ports are placed to allow
access to the kidney and site of tumour. Using ultrasound guidance the cryoprobe
is placed in the centre of the lesion. The probe then is cooled to minus Ç190
Celsius creating an ice ball. Using ultrasound and specially designed temperature
probes, the tumour and tissue surrounding it for 1cm. is cooled to minus Ç40
Celsius.
The advantage
includes minimally invasive (no blood loss, no surgical incision, outpatient
surgery) and short recuperation period. The procedure can be repeated if the
first cryosurgery has failed, radical surgery is still an option if the first
cryosurgery fails.
Several
investigators have performed and followed patients undergoing cryosurgery
of kidney cancer. Operative time is under 2 hours - hospital stay is 3 days
or less, estimated blood loss is negligible and complications are extremely
rare.
Results
in terms of cancer control are promising. Patients on follow-up CT scan have
has no evidence of recurrence with follow-up out to 5 years. In patients who
underwent biopsy of the cryosurgically-treated cancer no evidence of tumour
was identified. This technique has great promise in the arsenal against kidney
cancer. Unfortunately this treatment is not widely available due to the slow
training of the specialists and the availability of the unique equipment used
in the surgery. At this time, only a few hospitals in Europe are able to use
this procedure, it is not available in the United Kingdom on the NHS yet.
Back to the top
|